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SUMMARY
A 36-year-old woman was admitted for recurring chest pain and hemoptysis. Blood
pressure in the right and left arms was equal, and no murmurs or bruits were heard. Body
temperature was normal on admission and remained within the normal range during the
hospital stay. C-reactive protein was slightly elevated (2.3 mg/dL) and lupus anticoagulant
was positive. Angiography showed no abnormality of the aorta or its branches, but the left
pulmonary artery showed occlusion at the proximal portion. Computed tomography (CT)
revealed segmental wall thickening of the thoracic aorta. Fluorine-18-fluorodeoxyglucose
positron emission tomography (18FDG PET) showed high uptake in the proximal portion
of the left pulmonary artery and in the thoracic aorta with wall thickening on CT. Based
on these findings, a diagnosis of Takayasu's arteritis associated with antiphospholipid syn-
drome was made and high-dose steroid therapy (prednisolone 30 mg/day) was started.
Two months later, the C-reactive protein level had decreased from 2.3 mg/dL to 1.1 mg/
dL, and both the focal wall thickening and 18FDG uptake of the thoracic aorta were
decreased. 18FDG PET was useful for evaluating the efficacy of the steroid therapy in
addition to making a diagnosis of Takayasu's arteritis associated with antiphospholipid
syndrome.  (Int Heart J 2006; 47: 311-317)
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ALTHOUGH Takayasu's arteritis is a well-known disease,1,2) it is relatively rare.
The disease has various stages, and the symptoms and other clinical manifesta-
tions are different in each stage. Takayasu's arteritis affects the pulmonary artery
as well as the aorta,3-5) and pulmonary artery involvement predominates in some
cases.5,6) On the other hand, antiphospholipid syndrome is characterized by asso-
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ciated arterial and venous thrombotic events. We encountered a patient with left
pulmonary artery occlusion and positivity for lupus anticoagulant. The possibility
of an association between the Takayasu's arteritis and antiphospholipid syndrome
was considered. Several recent reports have described the usefulness of fluorine-
18-fluorodeoxyglucose positron emission tomography (18FDG PET) for the eval-
uation of systemic inflammatory heart diseases.7-9) Furthermore, the usefulness of
18FDG PET/CT for the assessment of active atherosclerosis that contains an
inflammatory component has been reported.10-13) 
Therefore, we performed 18FDG PET for Takayasu's arteritis associated with
antiphospholipid syndrome and found it to be useful for both the diagnosis and
assessment of the condition of the arteritis during treatment.
CASE PRESENTATION
A 36-year-old woman with no history of pregnancy or abortion was admit-
ted with recurrent chest pain and hemoptysis. Her symptoms had begun 8 months
before, and showed no improvement. On physical examination, the blood pres-
sure in her right and left arms was almost equal (100/52 mmHg), and no heart
murmurs or vascular bruits in the neck, chest, or abdomen could be heard. Body
temperature was 36.2°C on admission, and remained within the normal range
during her hospital stay. On admission, the C-reactive protein (CRP) level was
slightly elevated (2.3 mg/dL) and the erythrocyte sedimentation rate was 70 mm/
hr. The activated partial thromboplastin and prothrombin times were 42 seconds
Figure 1. Left panel: Pulmonary blood flow scintigraphy shows no uptake in the left lung. Right
panel: The left pulmonary artery is occluded at the proximal portion on pulmonary arteriography
(black arrow). ANT indicates anterior.
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and 12 seconds, respectively. The antithrombin III, protein S, and protein C levels
were within normal limits. Antinuclear antibody and anti-double-stranded-DNA
antibody, proteinase-3-anti-neutrophil cytoplasmic antibody, and myeloperoxi-
dase-anti-neutrophil cytoplasmic antibody were not detected and tests for syphilis
were negative. Although IgG-anticardiolipin antibodies and anticardiolipin-β2-
glycoprotein I complex antibody were negative, lupus anticoagulant was positive.
Pulmonary perfusion scintigraphy showed no uptake in the left lung, and pulmo-
nary arteriography showed a proximal occlusion of the left pulmonary artery
Figure 2. Computed tomography. A: Before treatment. White arrows show segmental wall
thickening in the thoracic aorta. The proximal part of the left pulmonary artery is occluded. B:
Two months after starting steroid therapy, the wall thickening in the aorta had disappeared.
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(Figure 1). Computed tomography (CT) showed segmental thickening of the wall
of the thoracic aorta (Figure 2A). In this patient, the possibility of the coexistence
of Takayasu's arteritis and antiphospholipid syndrome was considered. Angiogra-
phy of the aorta disclosed no stenosis, occlusion, or dilation of the aorta or its
branches, and the wall of the aorta was smooth (Figure 3). Ophthalmologic find-
ings were also normal. To confirm the inflammatory change of the vascular walls,
18FDG PET/CT imaging (e-NTEGRA; GE Medical System, USA) was per-
formed after more than 6 hours of fasting. 18FDG PET demonstrated high uptake
in the proximal portion of the left pulmonary artery and in the wall of the thoracic
aorta with thickening in the CT (Figure 4). We concluded that the uptake of
Figure 4. Computed tomography (left), fluorine-18-fluorodeoxyglucose positron emission
tomography (center), and fusion images (right) before steroid treatment. High uptake of 18FDG
PET was observed in the proximal portion of the left pulmonary artery and in the wall of the
thoracic aorta that showed wall thickening on CT.
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18FDG PET most likely reflected inflammation of the arterial wall, and made a
diagnosis of Takayasu's arteritis. High-dose steroid therapy (prednisolone 30 mg/
day) was then started. Two months later, the C-reactive protein level had
decreased from 2.3 mg/dL to 1.1 mg/dL. In addition, thickening of the thoracic
aorta wall had decreased (Figure 2B) and the high uptake on 18FDG PET had dis-
appeared (Figure 5).
DISCUSSION
Although the angiographic findings for the aorta in this patient were normal,
the mild increase in CRP and segmental wall thickening of the thoracic aorta on
CT suggested the likelihood of an inflammatory disease such as Takayasu's arteri-
tis. On the other hand, however, a few reports have described an association
between arteritis and antiphospholipid syndrome,14-16) although such an associa-
Figure 5. High uptake of fluorine-18-fluorodeoxyglucose positron emission tomography (18FDG PET)
in the aortic wall disappeared after 2 months of steroid therapy. A (upper panels): Before steroid therapy.
B (lower panels): After steroid therapy. CT indicates computed tomography.
A
B
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tion is uncommon. Furthermore, classically antiphospholipid syndrome is not
considered as a vasculitis, and corticosteroids are not effective. In contrast, they
are effective for Takayasu's arteritis. Therefore, it was important to confirm the
existence of arteritis associated with antiphospholipid syndrome in this patient.
We hesitated to treat this patient until a conclusive diagnosis of arteritis could be
made. Even high-dose steroid therapy is not particularly effective for antiphos-
pholipid syndrome, and carries a risk of considerable side effects.
Glycolytic metabolism is increased in inflammatory lesions and the useful-
ness of 18FDG PET for the evaluation of systemic inflammatory heart diseases
and active atherosclerosis which contains the inflammatory component has been
reported.7-13) Therefore, we performed 18FDG PET in order to detect inflammation
in this patient. The results of 18FDG PET study permitted a conclusive diagnosis
of arteritis and an initiation of high-dose steroid therapy. 
The early stage of Takayasu's arteritis shows inflammatory thickening of the
aortic wall, while in the advanced stage, the aorta exhibits stenosis, occlusion, or
aneurysm formation. Thus, initiation of steroid therapy during the early phase of
arteritis is important to prevent irreversible structural changes to the aortic wall.
Meller, et al17) performed 18FDG PET in 5 patients with early Takayasu's arteritis
and high uptake of 18FDG PET in the wall of the aorta was noted in all. They
emphasized the usefulness of 18FDG PET for the diagnosis of early Takayasu's
arteritis. In our case, 18FDG PET was very useful for the diagnosis of pulmonary
artery and thoracic aorta involvement in the Takayasu's arteritis. In addition,
18FDG PET was also useful to evaluate the efficacy of steroid therapy.
The present patient gave permission for publication of the report and 18FDG
PET for arteritis was approved by our Hospital Ethics Committee.
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